Search
for

    Did you mean Androgenetic Alopecia?
    GlossaryAndrogenetic Alopecia

    genetic hair loss influenced by androgens, often hereditary

    Androgenetic Alopecia, commonly known as Male Pattern Baldness or Female Pattern Baldness, is a genetic condition characterized by progressive hair thinning and loss. It is influenced by androgens (male hormones) and typically follows a recognizable pattern, such as a receding hairline in men and diffuse thinning on the crown in women. This condition is the most common cause of hair loss, affecting both genders, and is often hereditary.

    Related Terms

    Products matching "progressive androgenetic alopecia"

    Tracking 1 products like 234 Tricology Intensive Hair Loss Shampoo 200ml from by companies like Farmacia Tristaina / Andorra. View product »

    Learn

    5 / 11 results

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Comparison of options: topical vs medication

      in Female  1 upvotes 1 year ago
      A user diagnosed with AGA is seeking advice on hair loss treatments, comparing topical Minoxidil, Spironolactone, and Finasteride to oral medications and natural methods like dermastamping, PRP, and LED light. They are concerned about side effects and effectiveness, especially given their existing fatigue.

      community Bicalutamide vs Finasteride for female AGA plus TE

      in Female  3 upvotes 3 weeks ago
      OP is considering Bicalutamide for female AGA and TE but is concerned about its side effects and effectiveness compared to Finasteride. OP is also using Minoxidil and Spironolactone but is experiencing significant shedding and is unsure if it's androgen-driven or due to Minoxidil changes.

      community The MPB itch aka DHT itch is very real.

      in Chat  9 upvotes 3 years ago
      Hair loss itch is caused by DHT attacking follicles and stimulating nerves. Finasteride users who respond well don't experience this itch.

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  120 upvotes 5 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.